跳转至内容
Merck
CN

A7856

Sigma-Aldrich

阿西莫司

≥99% (TLC)

别名:

2-羧基-5-甲基吡嗪4-氧化物, 5-甲基吡嗪羧酸4-氧化物

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C6H6N2O3
化学文摘社编号:
分子量:
154.12
EC 号:
MDL编号:
UNSPSC代码:
12352205
NACRES:
NA.79
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

方案

≥99% (TLC)

表单

powder

颜色

off-white to faint yellow

mp

177-180 °C

储存温度

2-8°C

SMILES字符串

[n+]1(c(cncc1C(=O)O)C)[O-]

InChI

1S/C6H6N2O3/c1-4-2-7-3-5(6(9)10)8(4)11/h2-3H,1H3,(H,9,10)

InChI key

DNRXJHATQULEHC-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

生化/生理作用

已经研究了烟酸衍生的血管舒张剂的降脂作用。
阿昔莫司又称氧甲吡嗪,是一种烟酸类似物。它可用作抗脂解药和血管扩张剂。阿西莫司可用于胰岛素和生长素释放肽相关的各种代谢研究。它可降低总胆固醇和总甘油三酯,从而有助于治疗高脂血症。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Hanna-Riikka Lehto et al.
The Journal of clinical endocrinology and metabolism, 97(9), 3277-3284 (2012-07-05)
We tested the hypothesis that a persistent reduction in free fatty acid (FFA) levels improves cardiac function and systemic insulin sensitivity via a reduction in the myocardial and skeletal muscle adiposities and a modulation in adipokine release. Study subjects (body
Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia
Taskinen MR and Nikkila EA
Atherosclerosis, 69(2-3), 249-255 (1988)
Acyl ghrelin induces insulin resistance independently of GH, cortisol, and free fatty acids
Vestergaard ET, et al.
Scientific Reports, 7, 42706-42706 (2017)
Ee L Lim et al.
Clinical science (London, England : 1979), 121(4), 169-177 (2011-03-11)
Suppression of lipolysis by acipimox is known to improve insulin-stimulated glucose disposal, and this is an important phenomenon. The mechanism has been assumed to be an enhancement of glucose storage as glycogen, but no direct measurement has tested this concept
J Huang et al.
Drug research, 63(2), 79-83 (2013-03-01)
The study was designed to compare the pharmacokinetic parameters and relative bioavailability of a newly generic acipimox 250-mg tablets (test formulation) with a branded 250-mg tablets (reference formulation). A single-dose, randomized-sequence, 2-way crossover study was conducted in 20 healthy Chinese

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持